GMO Pepabo, Inc. provided consolidated earnings guidance for the year ending December 31, 2024. For the year, the company expects net sales of ¥10,963 million, operating profit of ¥700 million, profit attributable to owners of parent ¥421 million and basic earnings per share of ¥79.95.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,340 JPY | -0.74% | +0.90% | +14.63% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.63% | 45.25M | |
+18.26% | 413B | |
+13.10% | 237B | |
+7.63% | 138B | |
+16.48% | 101B | |
+16.77% | 83.51B | |
+49.24% | 55.82B | |
+30.71% | 52.22B | |
+4.74% | 37.38B | |
+15.33% | 33.94B |
- Stock Market
- Equities
- 3633 Stock
- News GMO Pepabo, Inc.
- GMO Pepabo, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024